Windtree Therapeutics, Inc. (WINT) Stock Surged 40.01% Pre-Market, Here’s Why
Windtree Therapeutics, Inc. (WINT) stock soared 40.01% in the pre-market trading session at the price of $1.40 after reporting topline data from its SEISMiC study. Windtree is advancing numerous next-gen interventions to treat acute pulmonary and cardiovascular diseases. Using the latest clinical, technological, and scientific techniques, WINT is formulating multi-asset compounds with a capacity to …
Windtree Therapeutics, Inc. (WINT) Stock Surged 40.01% Pre-Market, Here’s Why Read More »